Novel recurrently mutated genes and a prognostic mutation signature in colorectal cancer

Conclusions The application of next-generation sequencing has led to the identification of three novel significantly mutated genes in CRC and a mutation signature that predicts survival outcomes for stratifying patients with CRC independent of TNM staging.

http://gut.bmj.com/cgi/content/short/64/4/636?rss=1

Source: Gut - March 6, 2015 Category: Gastroenterology Authors: Yu, J., Wu, W. K. K., Li, X., He, J., Li, X.-X., Ng, S. S. M., Yu, C., Gao, Z., Yang, J., Li, M., Wang, Q., Liang, Q., Pan, Y., Tong, J. H., To, K. F., Wong, N., Zhang, N., Chen, J., Lu, Y., Lai, P. B. S., Chan, F. K. L., Li, Y., Kung, H.-F., Yang, H., Wa Tags: Open access, Colon cancer Source Type: research